January 14, 2020
Neptune said the months-long sale generated US$4 million in net proceeds, a move geared at monetizing the firm’s non-core investments.
November 26, 2019
The company announced that the last patient completed their final visit in its TRILOGY 1 pivotal Phase 3 clinical trial...
November 18, 2019
According to the announcement, CaPre demonstrated insulin secretion, which its counterpart metformin is not able to do.
October 13, 2019
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
October 8, 2019
With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
September 30, 2019
The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in...
September 9, 2019
Acasti Pharma (NASDAQ:ACST, TSXV:ACST) has announced the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) has awarded it...